Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 5.92 0.3 (5.34%) Market Cap: 839.71 Mil Enterprise Value: 780.08 Mil PE Ratio: 0 PB Ratio: 2.43 GF Score: 74/100

Maravai LifeSciences Holdings Inc at Stifel Healthcare Conference Transcript

Nov 14, 2023 / 03:55PM GMT
Release Date Price: $5.17 (+4.44%)
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

Okay. Welcome back to the 2023 Stifel Healthcare Conference. I am Dan Arias, and we are on the life sciences track here. Happy to have Maravai with us. CEO, Trey Martin; and CFO, Kevin Herde. Guys, thanks a bunch for being here.

Trey, I think maybe a good place to start would just be the CEO transition. You've been on the job for a few months. Previously, you were at Danaher, and you were running a different type of business there but adjacent, nonetheless.

Questions & Answers

Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

Maybe you can just talk a little bit about the strategy that you see for the company, the things that Maravai did well before and then the things you'd like to see Maravai do better, going forward?

William E. Martin
Maravai LifeSciences Holdings, Inc. - CEO

Sure. The -- my history actually in serving a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot